Zynex (ZYXI) Competitors $2.04 -0.15 (-6.85%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$2.04 0.00 (-0.20%) As of 06/11/2025 06:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ZYXI vs. NYXH, ZIMV, SMTI, SNWV, STIM, CATX, TCMD, NVRO, DRTS, and TLSIShould you be buying Zynex stock or one of its competitors? The main competitors of Zynex include Nyxoah (NYXH), ZimVie (ZIMV), Sanara MedTech (SMTI), SANUWAVE Health (SNWV), Neuronetics (STIM), Perspective Therapeutics (CATX), Tactile Systems Technology (TCMD), Nevro (NVRO), Alpha Tau Medical (DRTS), and TriSalus Life Sciences (TLSI). These companies are all part of the "medical equipment" industry. Zynex vs. Its Competitors Nyxoah ZimVie Sanara MedTech SANUWAVE Health Neuronetics Perspective Therapeutics Tactile Systems Technology Nevro Alpha Tau Medical TriSalus Life Sciences Nyxoah (NASDAQ:NYXH) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, profitability, institutional ownership, earnings, community ranking, dividends, risk and analyst recommendations. Does the media prefer NYXH or ZYXI? In the previous week, Nyxoah had 5 more articles in the media than Zynex. MarketBeat recorded 6 mentions for Nyxoah and 1 mentions for Zynex. Zynex's average media sentiment score of 1.87 beat Nyxoah's score of 1.54 indicating that Zynex is being referred to more favorably in the news media. Company Overall Sentiment Nyxoah Very Positive Zynex Very Positive Do analysts recommend NYXH or ZYXI? Nyxoah presently has a consensus target price of $14.50, indicating a potential upside of 86.74%. Zynex has a consensus target price of $6.00, indicating a potential upside of 195.57%. Given Zynex's higher probable upside, analysts plainly believe Zynex is more favorable than Nyxoah.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nyxoah 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Zynex 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Does the MarketBeat Community favor NYXH or ZYXI? Nyxoah received 11 more outperform votes than Zynex when rated by MarketBeat users. Likewise, 73.68% of users gave Nyxoah an outperform vote while only 55.36% of users gave Zynex an outperform vote. CompanyUnderperformOutperformNyxoahOutperform Votes4273.68% Underperform Votes1526.32% ZynexOutperform Votes3155.36% Underperform Votes2544.64% Which has better valuation and earnings, NYXH or ZYXI? Zynex has higher revenue and earnings than Nyxoah. Zynex is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNyxoah$4.36M60.60-$46.77M-$2.13-3.65Zynex$172.40M0.36$9.73M-$0.24-8.46 Do insiders and institutionals have more ownership in NYXH or ZYXI? 29.7% of Zynex shares are owned by institutional investors. 17.1% of Nyxoah shares are owned by company insiders. Comparatively, 49.3% of Zynex shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has more risk & volatility, NYXH or ZYXI? Nyxoah has a beta of 1.65, indicating that its share price is 65% more volatile than the S&P 500. Comparatively, Zynex has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500. Is NYXH or ZYXI more profitable? Zynex has a net margin of 2.49% compared to Nyxoah's net margin of -1,043.93%. Zynex's return on equity of 13.05% beat Nyxoah's return on equity.Company Net Margins Return on Equity Return on Assets Nyxoah-1,043.93% -51.68% -40.11% Zynex 2.49%13.05%3.78% SummaryZynex beats Nyxoah on 11 of the 18 factors compared between the two stocks. Get Zynex News Delivered to You Automatically Sign up to receive the latest news and ratings for ZYXI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ZYXI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZYXI vs. The Competition Export to ExcelMetricZynexElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$61.39M$3.38B$5.58B$8.61BDividend YieldN/A1.76%5.27%4.19%P/E Ratio13.5318.2927.2920.07Price / Sales0.36202.73410.86158.91Price / Cash18.0144.0938.2534.64Price / Book1.493.927.124.71Net Income$9.73M$94.03M$3.23B$247.80M7 Day Performance-5.58%2.42%2.99%2.30%1 Month Performance-2.40%13.83%12.39%9.55%1 Year Performance-78.08%22.83%31.73%14.92% Zynex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZYXIZynex2.9994 of 5 stars$2.04-6.8%$6.00+194.1%-78.0%$61.69M$172.40M13.60770Positive NewsNYXHNyxoah2.5647 of 5 stars$7.74+0.9%$14.50+87.3%-8.5%$263.62M$4.36M-4.14110Short Interest ↑Analyst RevisionZIMVZimVie3.2014 of 5 stars$9.39+0.1%$16.33+73.9%-42.6%$261.48M$443.55M-0.722,700Positive NewsSMTISanara MedTech1.9546 of 5 stars$29.07-1.4%$49.50+70.3%-6.6%$258.37M$91.57M-29.3660Positive NewsAnalyst RevisionSNWVSANUWAVE HealthN/A$30.16+8.1%N/AN/A$258.05M$36.19M-6.6140High Trading VolumeSTIMNeuronetics2.128 of 5 stars$3.72flat$5.50+47.8%+90.0%$244.85M$89.45M-3.02180Positive NewsCATXPerspective Therapeutics2.8423 of 5 stars$3.23-2.7%$12.63+290.9%-74.5%$239.76M$1.43M0.0070Analyst RevisionGap UpTCMDTactile Systems Technology3.8271 of 5 stars$10.23+1.9%$16.00+56.4%-17.3%$237.83M$293.16M14.61980Positive NewsNVRONevro0.185 of 5 stars$5.85+0.1%$5.36-8.3%-36.8%$224.32M$408.52M-3.091,090News CoverageDRTSAlpha Tau Medical2.9317 of 5 stars$3.13+3.6%$8.00+155.6%+33.5%$220.29MN/A-7.2880Positive NewsHigh Trading VolumeTLSITriSalus Life Sciences3.643 of 5 stars$5.59+3.7%$10.75+92.3%-11.9%$211.52M$32.14M-2.24106Positive NewsShort Interest ↓Analyst RevisionGap Up Related Companies and Tools Related Companies Nyxoah Alternatives ZimVie Alternatives Sanara MedTech Alternatives SANUWAVE Health Alternatives Neuronetics Alternatives Perspective Therapeutics Alternatives Tactile Systems Technology Alternatives Nevro Alternatives Alpha Tau Medical Alternatives TriSalus Life Sciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ZYXI) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBillionaires are piling into this gold investmentBillionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zynex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zynex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ZYXI Stock Free ZYXI Stock Alerts